Cagent Vascular
Cagent Vascular

Cagent Vascular

Measured by AhrefsDR26Ahrefs DR: 26/100. Below median. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent50Agent Readiness: 50/100. Top 25%. Measured by StartupHub.ai. Median 41.Measured by StartupHub.aiTrust80Data Trust: 80/100. Top 25%. Measured by StartupHub.ai. Median 61.

Developing innovative intravascular lithotripsy technology for treating calcified peripheral artery disease.

2015ActiveWayne, USA

About

Cagent Vascular, Inc. is a medical device company focused on developing and commercializing innovative intravascular lithotripsy (IVL) technology. Their flagship product, the Serranator SONIC IVL System, is designed to treat calcified lesions in peripheral arteries, a common and challenging condition in patients with Critical Limb Ischemia (CLI).

Key facts

Website
cagentvascular.com
Headquarters
Wayne, Pennsylvania, USA
Founded
2015
Total funding
$41M (Series D)
Business model
B2B

Funding rounds

Funding rounds raised by Cagent Vascular
DateRoundAmountLead investors
19 May 2026Series D$41M

Tech stack

Detected on cagentvascular.com, last scanned 29 Oct 2026.

Analytics
Google Analytics 4, Google Tag Manager
CMS / Builders
Squarespace
CDN
Cloudflare
Email provider
Microsoft 365
Email marketing
Salesforce Pardot

Cagent Vascular scores 26. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

What does Cagent Vascular do?

The company recently announced the completion of its first human-use cases with the Serranator SONIC IVL System and secured $41 million in Series D funding.

Is Cagent Vascular trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Cagent Vascular is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Cagent Vascular raised?

Cagent Vascular has raised a total of $41M in funding. The most recent round on record is Series D.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for Cagent Vascular